Press Releases
January 28, 2025
PRESS RELEASE
MolecuLight Announces Presentation of its Clinical and Surgical Benefits in Reconstructive...
January 9, 2025
PRESS RELEASE
MolecuLight Secures $27.5 Million From Hayfin, a Leading Healthcare Institutional Investor
May 30, 2024
PRESS RELEASE
MolecuLight’s Pioneering Fluorescence Imaging Technology Showcased in Prestigious Burns Journal...
May 2, 2024
PRESS RELEASE
MolecuLight Featured in 11 Presentations and Posters at European Wound Management Association...
January 25, 2024
PRESS RELEASE
MolecuLight Awarded Federal Supply Contract for the US Department of Veterans Affairs
November 21, 2023
PRESS RELEASE
United States Patent and Trademark Office (USPTO) Cancels All Claims of Swift Medical’s...
November 2, 2023
PRESS RELEASE
12 Posters and Presentations Featuring MolecuLight to be Presented at the SAWC Fall 2023...
September 21, 2023
PRESS RELEASE
Latest Clinical Evidence Presented at APWCA’s Wound Week™ 2023 Illustrates the Significant...
Archive
2023
July 6, 2023 —PRESS RELEASE
Seasoned Healthcare Executive David Bassin Joins the MolecuLight Board of Directors
May 23, 2023 —PRESS RELEASELargest Published Real-World Wound Imaging Study Reports MolecuLight® led to Wound Treatment Plan Changes in up to 53% Cases
May 3, 2023 —PRESS RELEASEMolecuLight Featured in Unprecedented 24 Presentations and Posters at European Wound Management Association (EWMA) 2023 Annual Conference
April 27, 2023 —PRESS RELEASEMolecuLight Partners with WoundZoom to Deliver Cloud-Based Wound Management Solution Integrated with its Point-of-Care Bacterial Imaging
April 25, 2023 —PRESS RELEASENew Publication Reveals MolecuLight Imaging Significantly Improved Detection of Bacterial Burden Across Patients of All Skin Tones
April 19, 2023 —PRESS RELEASEMolecuLight Successfully Completes SOC 2® Type I Audit and Accreditation
February 14, 2023 —PRESS RELEASEChronic Inhibitory Bacterial Load (CIBL): New Clinical Terminology for Elevated Levels of Bacteria in Wounds that Preclude Healing
2022
December 6, 2022 —PRESS RELEASE
MolecuLight Featured in Vizient Tech Watch as Key Technology for Visualizing Bacterial Burden and Helping to Reduce Surgical Site Infections
November 10, 2022 —PRESS RELEASEMolecuLight Featured in 10 Presentations and Posters at the AAWC 2022 Annual Conference
October 13, 2022 —PRESS RELEASE2,000+ Patients’ Worth of New MolecuLight Data to be Presented at the SAWC Fall 2022 Conference
September 29, 2022 —PRESS RELEASEMolecuLight Point-of-Care Wound Imaging Devices Awarded Group Purchasing Agreement with AllSpire Health GPO
September 13, 2022 —PRESS RELEASEMolecuLight Featured in 8 Presentations and Posters at Wounds Australia 2022 Conference
August 11, 2022 —PRESS RELEASEMolecuLight Secures Financing from BDC Canada and iGan Partners to Support its Commercial Expansion
July 13, 2022 —PRESS RELEASENewly Published RCT Shows MolecuLight Fluorescence Point-of-Care Imaging Improved 12-Week Wound Healing by 204% in Diabetic Foot Ulcers
July 7, 2022 —PRESS RELEASEMolecuLightDX™ Wins Award as a Top Innovation in Wound Care 2022 From Wound Management & Prevention Journal
June 29, 2022 —PRESS RELEASEFDA 510(k) Clearance Expands Labelling of MolecuLight i:X® to Include the Ability to Identify Regions Containing Elevated Load and More Bacterial Species
June 14, 2022 —PRESS RELEASEMolecuLight Awarded Point-of-Care Wound Imaging Devices Agreement with Premier, Inc.
June 1, 2022 —PRESS RELEASEMolecuLight Added to the ISWCAP 2022 Consensus Guidelines for Optimising Prevention of Surgical Wound Complications
April 6, 2022 —PRESS RELEASEMolecuLight i:X® Receives Regulatory Clearance and Reimbursement in South Korea
March 1, 2022 —PRESS RELEASEMolecuLight Featured in Unprecedented 32 Presentations and Posters at World Union of Wound Healing Societies (WUWHS) 2022 Conference
February 24, 2022 —PRESS RELEASELatest Clinical Evidence Presented at APWCA’s Wound Week™ 2022 Illustrates the Significant Clinical Utility of the MolecuLight Point-of-Care Imaging Platform
January 18, 2022 —PRESS RELEASENew Clinical Study Finds MolecuLight i:X® Point-of-Care Imaging Improved Sensitivity of Detecting Bacterial Burden in Surgical Site Wounds by 11-Fold
January 4, 2022 —PRESS RELEASESWK Holdings Provides $10M USD to MolecuLight to Support Global Commercial Expansion
2021
October 28, 2021 —PRESS RELEASE
Latest Clinical Evidence Presented at SAWC 2021 Illustrates the Significant Clinical Utility of the MolecuLight Point-of-Care Imaging Platform
October 19, 2021 —PRESS RELEASEJoerns Healthcare Introduces Point-of-Care Imaging to Wound Care Portfolio Through MolecuLight Partnership
October 14, 2021 —PRESS RELEASELaunch of New MolecuLightDX™ Device to Enable Point-of-Care Imaging of Wounds in New Expanding Market Segments
October 12, 2021 —PRESS RELEASEStudy of 236 patients reveals utility of MolecuLight i:X® in detection and management of wound-related cellulitis
September 23, 2021 —PRESS RELEASEMolecuLight i:X® Receives FDA 510(k) Clearance for the Device’s Ability to Detect Wounds Likely to Contain Pseudomonas Aeruginosa (PA)
July 7, 2021 —PRESS RELEASEIn new publication, 96% of clinicians state that treatment plans informed using the MolecuLight procedure led to improved wound healing – MolecuLight US
June 22, 2021 —PRESS RELEASEMolecuLight Signs LMT Surgical as New Distributor for Australia and New Zealand
May 18, 2021 —PRESS RELEASENovel Technology to Help Improve Wound Care in Canada Enabled Through CAN Health, Sunnybrook and MolecuLight Collaboration
May 6, 2021 —PRESS RELEASEMolecuLight Announces Integration of its i:X® Fluorescence Imaging Device with Net Health’s Tissue Analytics API Program
May 4, 2021 —PRESS RELEASEMolecuLight Receives Innovative Technology Contract from Vizient for its i:X® Fluorescence Wound Imaging Device
April 8, 2021 —PRESS RELEASEMolecuLight Announces the Appointment of 11 Global Distributors
March 9, 2021 —PRESS RELEASEMolecuLight i:X® Platform Available to 650 Long-Term Healthcare Facilities Through Synergy HealthCare Alliance, LLC
March 2, 2021 —PRESS RELEASEResults Published in Study Show MolecuLight Fluorescence Point-of-Care Imaging Detected Pseudomonas Aeruginosa (PA) in Wounds with a PPV of 93%
2020
December 10, 2020 —PRESS RELEASE
Wound Care Plus, LLC Adopts the MolecuLight i:X® as a Standard Point-of-Care Device for its Wound Care Service Offering to the Long-Term Care and Extended Care Markets
November 25, 2020 —PRESS RELEASEResults Published from 2-Year Study of 229 Wounds Treated in an NHS Clinic Show Fluorescence Point-of-Care Imaging Improved Wound Healing Rates by 23%
September 29, 2020 —PRESS RELEASEResults from 350-Patient FLAAG Trial Show MolecuLight Point-of-Care Imaging Improves Detection of High Bacterial Burden in Wounds Four-fold over Standard of Care Assessment
August 12, 2020 —PRESS RELEASEMolecuLight Announces Availability of its MolecuLight i:X® Platform on Epic’s App Orchard
July 9, 2020 —PRESS RELEASEMolecuLight Launches i:X® Sterile Surgical Sleeve for Imaging of Bacteria in Wounds in a Surgical Setting
June 15, 2020 —PRESS RELEASEMolecuLight i:X® Platform Available to 9,000 Healthcare Facilities Through MAGNET GROUP GPO
June 11, 2020 —PRESS RELEASEMolecuLight Announces CMS has Assigned an APC Reimbursement Code for its MolecuLight i:X® Procedure for Bacterial Imaging using Fluorescence
April 1, 2020 —PRESS RELEASEMolecuLight Announces Industry Partnership and Virtual Exhibit of its MolecuLight i:X® Platform at WoundCon™ 2020, the Largest Conference for Wound Care
March 3, 2020 —PRESS RELEASEFirst Published Study to Report In Vitro Detection of Fluorescence from Bacteria in Biofilm with Point-of-care Wound Imaging Device
February 20, 2020 —PRESS RELEASENew MolecuLight i:X® Upgrade Enables Faster, More Accurate Digital Wound Measurement
February 13, 2020 —PRESS RELEASEAmerican Medical Association Issues Category lll CPT Code for Real-time Fluorescence Wound Imaging
February 11, 2020 —PRESS RELEASEUniversity Hospitals Ahuja Medical Center Physician First in Ohio to Use Wound Care Imaging Device in Clinical Setting
2019
December 5, 2019 —PRESS RELEASE
MolecuLight Receives FDA 510(k) Clearance for its i:X® Handheld Fluorescence Imaging Device for Wound Management
November 4, 2019 —PRESS RELEASEAMA Announces Approval for Category lll CPT Code for Real-time Fluorescence Wound Imaging
October 11, 2019 —PRESS RELEASEClinical Results from the MolecuLight i:X® Fluorescence Imaging System are Featured in Two Clinical Talks and Seven Posters at the SAWC Fall 2019 Annual Conference
October 4, 2019 —PRESS RELEASEResults from Clinical Studies using MolecuLight i:X® Fluorescence Imaging System Featured Prominently at the Wounds Canada 2019 Annual Conference
September 13, 2019 —PRESS RELEASEPublished Study Finds 9/10 Chronic Wound Patients Likely to Have Received More Appropriately Triaged Care with Information from the MolecuLight i:X® Imaging Device
August 19, 2019 —PRESS RELEASEOxford Finance LLC Provides $7.5M USD Term Loan to MolecuLight® Inc. to Support Global Commercial Expansion
August 14, 2019 —PRESS RELEASEphotonamic GmbH & Co. KG (Germany) Acquires the Oncology Business from MolecuLight® Inc. (Canada)
2018
August 14, 2018 —PRESS RELEASE
MolecuLight® Inc.’s first-of-its-kind handheld fluorescence imaging device receives FDA De Novo clearance for US wound care market
June 2, 2018 —NEWSMolecuLight® partners with SerenaGroup for a multi-center clinical trial
May 17, 2018 —NEWSMolecuLight clinical insights from EWMA 2018
January 15, 2018 —NEWSNew Publication: Efficacy of an imaging device at identifying the presence of bacteria in wounds at a plastic surgery outpatients clinic
2017
December 7, 2017 —BLOG
The role of the MolecuLight i:X in potential improvement of current debridement practices
October 17, 2017 —PRESS RELEASEMolecuLight announces appointment of Anil Amlani as CEO
August 30, 2017 —BLOGPredicting the presence of pathogenic bacteria in wounds
August 2, 2017 —BLOGFish skin for human wounds: Iceland’s pioneering treatment
August 2, 2017 —NEWSNew Publication: Predicting the presence of pathogenic bacteria in wounds
May 16, 2017 —NEWSRose Raizman receives EWMA e-poster prize
May 12, 2017 —NEWSImproving antimicrobial stewardship practices with the MolecuLight i:X
April 24, 2017 —NEWSHow will fluorescence imaging impact wound care?
April 24, 2017 —NEWSEWMA 2017 update
April 21, 2017 —NEWSThe use of MolecuLight i:X in managing burns
April 5, 2017 —NEWSMolecuLight at SAWC Spring 2017
March 30, 2017 —NEWSMolecuLight i:X featured in the Toronto Star.
March 6, 2017 —NEWSMolecuLight i:X performs better than Levine method to maximize sampling of treatment-relevant pathogens in chronic wounds.
February 27, 2017 —BLOGWill the ‘urgent need’ for new drugs be sufficient in the fight against bacteria?
February 24, 2017 —NEWSThe MolecuLight i:X a novel solution in the ever-increasing battle against antibiotic resistance?
January 16, 2017 —BLOGAntibiotic resistance continues to be a real issue
2016
December 23, 2016 —BLOG
